{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:48:28Z","timestamp":1794718108437,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T00:00:00Z","timestamp":1695081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["PJT-165967"],"award-info":[{"award-number":["PJT-165967"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["PJT-148656"],"award-info":[{"award-number":["PJT-148656"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["PJT-153317"],"award-info":[{"award-number":["PJT-153317"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington\u2019s Disease (HD) is an inherited autosomal dominant neurodegenerative disorder that leads to progressive motor and cognitive impairment due to the expansion of a polyglutamine (CAG) repeat in the N-terminal region of the huntingtin (Htt) protein. The creation of HD mouse models represents a critical step in the research for HD treatment. Among the currently available HD mouse models, the zQ175 knock-in mouse line is the first to display robust disease phenotype on a heterozygous background. The newer FDNQ175 mouse model is derived from the zQ175 mouse line and presents a more aggressive phenotype. Moreover, increasing evidence has implicated sex as a contributing factor in the progression of HD symptoms. Here, we compared the progression of HD phenotypes in male and female heterozygous FDNQ175 mice. We found that both male and female heterozygous mice showed deficits in forelimb grip strength and cognition as early as 6 months of age. However, female FDNQ175 mice were less vulnerable to HD-associated decline in limb coordination and movement. Neither male nor female FDNQ175 mice exhibited reduced locomotor activity in the open field or exhibit consistent differences in anxiety at 6\u201312 months of age. Both male and female FDNQ175 mice exhibited increased numbers of huntingtin aggregates with age and 8-month-old female FDNQ175 mice had significantly more aggregates than their male counterparts. Taken together, our results provide further evidence that sex can influence the progression of HD phenotype in preclinical animal models and must be taken into consideration for future HD research.<\/jats:p>","DOI":"10.1186\/s13041-023-01054-6","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T10:02:32Z","timestamp":1695117752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Huntington\u2019s disease phenotype progression in male and female heterozygous FDNQ175 mice"],"prefix":"10.1186","volume":"16","author":[{"given":"Si Han","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tash-Lynn L.","family":"Colson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled S.","family":"Abd-Elrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-7312","authenticated-orcid":false,"given":"Stephen S. G.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,19]]},"reference":[{"issue":"20","key":"1054_CR1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM198611133152006","volume":"315","author":"JB Martin","year":"1986","unstructured":"Martin JB, Gusella JF. Huntingtons disease. N Engl J Med. 1986;315(20):1267\u201376.","journal-title":"N Engl J Med"},{"issue":"1","key":"1054_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA. Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis. 2010;5(1):1\u20138.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1054_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srinidhi L, Barnes G, Taylor SA, James M, Groot N. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell. 1993;72(6):971\u201383.","journal-title":"Cell"},{"issue":"5334","key":"1054_CR4","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel J, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997;277(5334):1990\u20133.","journal-title":"Science"},{"issue":"4","key":"1054_CR5","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman MA. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet. 1993;4(4):398\u2013403.","journal-title":"Nat Genet"},{"issue":"1","key":"1054_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ana.410390120","volume":"39","author":"S Furtado","year":"1996","unstructured":"Furtado S, Suchowersky O, Rewcastle NB, Graham L, Klimek ML, Garber A. Relationship between trinucliotide repeats and neuropathological changes in Huntington\u2019s diease. Ann Neurol. 1996;39(1):132\u20136.","journal-title":"Ann Neurol"},{"key":"1054_CR7","doi-asserted-by":"crossref","unstructured":"Ferrante RJ. (2009). Mouse models of Huntington\u2019s disease and methodological considerations for therapeutic trials. Biochimica et Biophysica Acta (BBA)-Molecular basis of Disease, 1792(6), 506\u201320.","DOI":"10.1016\/j.bbadis.2009.04.001"},{"issue":"12","key":"1054_CR8","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE. 2012;7(12):e49838.","journal-title":"PLoS ONE"},{"issue":"17","key":"1054_CR9","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1093\/hmg\/ddw212","volume":"25","author":"AL Southwell","year":"2016","unstructured":"Southwell AL, Smith-Dijak A, Kay C, Sepers M, Villanueva EB, Parsons MP, Xie Y, Anderson L, Felczak B, Waltl S. An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes. Hum Mol Genet. 2016;25(17):3654\u201375.","journal-title":"Hum Mol Genet"},{"issue":"17","key":"1054_CR10","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/hmg\/ddn159","volume":"17","author":"FJ Bode","year":"2008","unstructured":"Bode FJ, Stephan M, Suhling H, Pabst R, Straub RH, Raber KA, Bonin M, Nguyen HP, Riess O, Bauer A. Sex differences in a transgenic rat model of Huntington\u2019s disease: decreased 17\u03b2-estradiol levels correlate with reduced numbers of DARPP32 + neurons in males. Hum Mol Genet. 2008;17(17):2595\u2013609.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1054_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","volume":"178","author":"JL Dorner","year":"2007","unstructured":"Dorner JL, Miller BR, Barton SJ, Brock TJ, Rebec GV. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington\u2019s disease. Behav Brain Res. 2007;178(1):90\u20137.","journal-title":"Behav Brain Res"},{"issue":"2","key":"1054_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1021\/acsptsci.0c00013","volume":"3","author":"KS Abd-Elrahman","year":"2020","unstructured":"Abd-Elrahman KS, Hamilton A, Albaker A, Ferguson SS. mGluR5 contribution to neuropathology in Alzheimer mice is disease stage-dependent. ACS Pharmacol Translational Sci. 2020b;3(2):334\u201344.","journal-title":"ACS Pharmacol Translational Sci"},{"issue":"510","key":"1054_CR13","doi-asserted-by":"publisher","first-page":"eaan6387","DOI":"10.1126\/scisignal.aan6387","volume":"10","author":"KS Abd-Elrahman","year":"2017","unstructured":"Abd-Elrahman KS, Hamilton A, Hutchinson SR, Liu F, Russell RC, Ferguson SS. mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington\u2019s disease. Sci Signal. 2017;10(510):eaan6387.","journal-title":"Sci Signal"},{"key":"1054_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15750","author":"KS Abd-Elrahman","year":"2021","unstructured":"Abd-Elrahman KS, Sarasija S, Colson TLL, Ferguson SS. A M1 muscarinic acetylcholine receptor positive allosteric modulator improves pathology and cognitive deficits in female APPswe\/PSEN1\u2206E9 mice. Br J Pharmacol. 2021. https:\/\/doi.org\/10.1111\/bph.15750.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1054_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1124\/jpet.121.000735","volume":"379","author":"SH Li","year":"2021","unstructured":"Li SH, Colson TL, Abd-Elrahman KS, Ferguson SSG. Metabotropic glutamate receptor 2\/3 activation improves Motor Performance and reduces Pathology in heterozygous zQ175 Huntington Disease mice. J Pharmacol Exp Ther. 2021;379(1):74\u201384.","journal-title":"J Pharmacol Exp Ther"},{"key":"1054_CR16","doi-asserted-by":"publisher","first-page":"801757","DOI":"10.3389\/fnmol.2022.801757","volume":"15","author":"SH Li","year":"2022","unstructured":"Li SH, Colson TL, Abd-Elrahman KS, Ferguson SSG. Metabotropic glutamate receptor 5 antagonism reduces Pathology and differentially improves symptoms in male and female heterozygous zQ175 Huntington\u2019s mice. Front Mol Neurosci. 2022;15:801757. https:\/\/doi.org\/10.3389\/fnmol.2022.801757.","journal-title":"Front Mol Neurosci"},{"issue":"1\u20132","key":"1054_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","volume":"126","author":"H-G L\u00fcesse","year":"2001","unstructured":"L\u00fcesse H-G, Schiefer J, Spruenken A, Puls C, Block F, Kosinski CM. Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington\u2019s disease: behavioral testing and impact of diabetes mellitus. Behav Brain Res. 2001;126(1\u20132):185\u201395.","journal-title":"Behav Brain Res"},{"key":"1054_CR18","doi-asserted-by":"crossref","unstructured":"Paulsen JS, Miller AC, Hayes T, Shaw E. (2017). Cognitive and behavioral changes in Huntington disease before diagnosis. Handbook of clinical neurology, 144, 69\u201391.","DOI":"10.1016\/B978-0-12-801893-4.00006-7"},{"issue":"461","key":"1054_CR19","doi-asserted-by":"publisher","first-page":"eaar3959","DOI":"10.1126\/scitranslmed.aar3959","volume":"10","author":"AL Southwell","year":"2018","unstructured":"Southwell AL, Kordasiewicz HB, Langbehn D, Skotte NH, Parsons MP, Villanueva EB, Caron NS, \u00d8stergaard ME, Anderson LM, Xie Y. Huntingtin suppression restores cognitive function in a mouse model of Huntington\u2019s disease. Sci Transl Med. 2018;10(461):eaar3959.","journal-title":"Sci Transl Med"},{"issue":"10","key":"1054_CR20","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles C, Bates GP. Huntingtin and the molecular pathogenesis of Huntington\u2019s disease: Fourth in Molecular Medicine Review Series. EMBO Rep. 2004;5(10):958\u201363.","journal-title":"EMBO Rep"},{"key":"1054_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbr.2017.09.026","volume":"337","author":"JK Cao","year":"2018","unstructured":"Cao JK, Detloff PJ, Gardner RG, Stella N. Sex-dependent behavioral impairments in the HdhQ350\/+ mouse line. Behav Brain Res. 2018b;337:34\u201345.","journal-title":"Behav Brain Res"},{"issue":"7010","key":"1054_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004;431(7010):805\u201310.","journal-title":"Nature"},{"issue":"6","key":"1054_CR23","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.neubiorev.2009.03.004","volume":"33","author":"J Prodoehl","year":"2009","unstructured":"Prodoehl J, Corcos DM, Vaillancourt DE. Basal ganglia mechanisms underlying precision grip force control. Neurosci Biobehavioral Reviews. 2009;33(6):900\u20138.","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"1054_CR24","doi-asserted-by":"crossref","unstructured":"Ghosh R, Tabrizi SJ. (2018). Clinical features of Huntington\u2019s disease. Polyglutamine Disorders, 1\u201328.","DOI":"10.1007\/978-3-319-71779-1_1"},{"issue":"1","key":"1054_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1023\/A:1022166921766","volume":"12","author":"D Hennemann","year":"2003","unstructured":"Hennemann D. Diagnosis|\u2018Space cadet\u2019syndrome of female FVB\/n mice. Transgenic Res. 2003;12(1):59\u201369.","journal-title":"Transgenic Res"},{"issue":"6","key":"1054_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/laban0607-15","volume":"36","author":"MD Rosenbaum","year":"2007","unstructured":"Rosenbaum MD, VandeWoude S, Bielefeldt-Ohmann H. Sudden onset of mortality within a colony of FVB\/n mice. Lab Anim. 2007;36(6):15\u20135.","journal-title":"Lab Anim"},{"issue":"3","key":"1054_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrn2335","volume":"9","author":"CM Bird","year":"2008","unstructured":"Bird CM, Burgess N. The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci. 2008;9(3):182\u201394.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"1054_CR28","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.neuroscience.2010.08.012","volume":"170","author":"D Grove-Strawser","year":"2010","unstructured":"Grove-Strawser D, Boulware MI, Mermelstein PG. Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience. 2010;170(4):1045\u201355.","journal-title":"Neuroscience"},{"issue":"1","key":"1054_CR29","doi-asserted-by":"publisher","first-page":"8982","DOI":"10.1038\/s41598-022-13029-z","volume":"12","author":"JM de Souza","year":"2022","unstructured":"de Souza JM, Ferreira-Vieira TH, Maciel EM, Silva NC, Lima IBQ, Doria JG, Olmo IG, Ribeiro FM. mGluR5 ablation leads to age-related synaptic plasticity impairments and does not improve Huntington\u2019s disease phenotype. Sci Rep. 2022;12(1):8982.","journal-title":"Sci Rep"},{"issue":"4","key":"1054_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/bph.12164","volume":"169","author":"J Doria","year":"2013","unstructured":"Doria J, Silva F, De Souza J, Vieira L, Carvalho T, Reis H, Pereira G, Dobransky T, Ribeiro F. Metabotropic glutamate receptor 5 positive allosteric modulators are neuroprotective in a mouse model of H untington\u2019s disease. Br J Pharmacol. 2013;169(4):909\u201321.","journal-title":"Br J Pharmacol"},{"key":"1054_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fendo.2018.00173","volume":"9","author":"J Cao","year":"2018","unstructured":"Cao J, Willett JA, Dorris DM, Meitzen J. Sex differences in medium spiny neuron excitability and glutamatergic synaptic input: heterogeneity across striatal regions and evidence for estradiol-dependent sexual differentiation. Front Endocrinol. 2018a;9:173.","journal-title":"Front Endocrinol"},{"issue":"48","key":"1054_CR32","doi-asserted-by":"publisher","first-page":"16137","DOI":"10.1523\/JNEUROSCI.4161-10.2010","volume":"30","author":"T Smejkalova","year":"2010","unstructured":"Smejkalova T, Woolley CS. Estradiol acutely potentiates hippocampal excitatory synaptic transmission through a presynaptic mechanism. J Neurosci. 2010;30(48):16137\u201348.","journal-title":"J Neurosci"},{"issue":"2","key":"1054_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/s0006-8993(97)00449-6","volume":"761","author":"CE Weaver Jr","year":"1997","unstructured":"Weaver CE Jr, Park-Chung M, Gibbs TT, Farb DH. 17beta-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 1997;761(2):338\u201341. https:\/\/doi.org\/10.1016\/s0006-8993(97)00449-6.","journal-title":"Brain Res"},{"issue":"50","key":"1054_CR34","doi-asserted-by":"publisher","first-page":"12314","DOI":"10.1523\/JNEUROSCI.3011-17.2017","volume":"37","author":"JG Oberlander","year":"2017","unstructured":"Oberlander JG, Woolley CS. 17\u03b2-Estradiol acutely potentiates glutamatergic synaptic transmission in the hippocampus through distinct mechanisms in males and females. J Neurosci. 2017;37(50):12314\u201327.","journal-title":"J Neurosci"},{"issue":"1","key":"1054_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/jnnp.66.1.52","volume":"66","author":"T Foroud","year":"1999","unstructured":"Foroud T, Gray J, Ivashina J, Conneally PM. Differences in duration of Huntington\u2019s disease based on age at onset. J Neurol Neurosurg Psychiatry. 1999;66(1):52\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1054_CR36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/mdc3.13178","volume":"8","author":"S Hentosh","year":"2021","unstructured":"Hentosh S, Zhu L, Patino J, Furr JW, Rocha NP, Stimming F, E. Sex differences in Huntington\u2019s disease: evaluating the enroll-HD database. Mov Disorders Clin Pract. 2021;8(3):420\u20136.","journal-title":"Mov Disorders Clin Pract"},{"issue":"2","key":"1054_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.parkreldis.2012.09.012","volume":"19","author":"D Zielonka","year":"2013","unstructured":"Zielonka D, Marinus J, Roos RA, De Michele G, Di Donato S, Putter H, Marcinkowski J, Squitieri F, Bentivoglio AR, Landwehrmeyer GB. The influence of gender on phenotype and disease progression in patients with Huntington\u2019s disease. Parkinsonism Relat Disord. 2013;19(2):192\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1054_CR38","doi-asserted-by":"publisher","first-page":"e0147583","DOI":"10.1371\/journal.pone.0147583","volume":"11","author":"DA Kuljis","year":"2016","unstructured":"Kuljis DA, Gad L, Loh DH, MacDowell Kaswan Z, Hitchcock ON, Ghiani CA, Colwell CS. Sex differences in circadian dysfunction in the BACHD mouse model of Huntington\u2019s disease. PLoS ONE. 2016;11(2):e0147583.","journal-title":"PLoS ONE"},{"key":"1054_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.niox.2018.12.002","volume":"83","author":"FE Padovan-Neto","year":"2019","unstructured":"Padovan-Neto FE, Jurkowski L, Murray C, Stutzmann GE, Kwan M, Ghavami A, Beaumont V, Park LC, West AR. Age-and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington\u2019s disease. Nitric Oxide. 2019;83:40\u201350.","journal-title":"Nitric Oxide"},{"issue":"5","key":"1054_CR40","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0166-2236(99)01543-X","volume":"23","author":"ME Rice","year":"2000","unstructured":"Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000;23(5):209\u201316.","journal-title":"Trends Neurosci"},{"issue":"7197","key":"1054_CR41","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","volume":"453","author":"S-H Yang","year":"2008","unstructured":"Yang S-H, Cheng P-H, Banta H, Piotrowska-Nitsche K, Yang J-J, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J. Towards a transgenic model of Huntington\u2019s disease in a non-human primate. Nature. 2008;453(7197):921\u20134.","journal-title":"Nature"},{"issue":"662","key":"1054_CR42","doi-asserted-by":"publisher","first-page":"eabd2494","DOI":"10.1126\/scisignal.abd2494","volume":"13","author":"KS Abd-Elrahman","year":"2020","unstructured":"Abd-Elrahman KS, Albaker A, de Souza JM, Ribeiro FM, Schlossmacher MG, Tiberi M, Hamilton A, Ferguson SS. A\u03b2 oligomers induce pathophysiological mGluR5 signaling in Alzheimer\u2019s disease model mice in a sex-selective manner. Sci Signal. 2020a;13(662):eabd2494.","journal-title":"Sci Signal"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-023-01054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-023-01054-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-023-01054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T11:21:19Z","timestamp":1700306479000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-023-01054-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,19]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1054"],"URL":"https:\/\/doi.org\/10.1186\/s13041-023-01054-6","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,19]]},"assertion":[{"value":"20 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental protocols were approved by the University of Ottawa Institutional Animal Care Committee and were in accordance with the Canadian Council of Animal Care guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}